Get ready to dive into the future of healthcare with the Med-AI Web Hour, brought to you by Doctors AI. This exciting webinar features two esteemed speakers who are leaders in their fields. Dr. Ravi Kampelli will discuss how AI can be utilized to overcome barriers to healing. Following him, Dr. Surajit Ghorai will explore AI in Dermatology. Don’t miss this chance to gain insights from the forefront of AI in medicine and discover how these advancements are shaping the future of healthcare!

Med-AI Web Hour

Get ready to dive into the future of healthcare with the Med-AI Web Hour, brought to you by Doctors AI. This exciting webinar features two esteemed speakers who are leaders in their fields. Dr. Shelly Sharma (Vice-chairperson of the department of radiology, Sir Ganga Ram Hospital), will explore AI in Radiology. Following her, Dr. Atul Tiwari (Assistant Professor of pathology at Government Medical College, Chittorgarh) will discuss how AI is revolutionizing the field of Pathology. Don’t miss this chance to gain insights from the forefront of AI in medicine and discover how these advancements are shaping the future of healthcare!

Get ready to dive into the future of healthcare with the Med-AI Web Hour, brought to you by Doctors AI. This exciting webinar features two esteemed speakers who are leaders in their fields. Dr. Mudit Sabrawal, a renowned Diabetologist from New Delhi, will explore the transformative impact of Big Data and Predictive Analytics in Metabolic Disease Management. Following him, Dr. Shambo Samrat Samajdar, a Clinical Pharmacologist from Kolkata, will discuss how AI is revolutionizing Clinical Pharmacology, enhancing drug development, and improving patient care. The session will conclude with an engaging 15-minute panel discussion moderated by Dr. Bharat Saboo. Don’t miss this chance to gain insights from the forefront of AI in medicine and discover how these advancements are shaping the future of healthcare!

Nonalcoholic fatty liver disease (NAFLD) is a constellation of conditions ranging from simple hepatic steatosis to nonalcoholic steatohepatitis (NASH), with or without fibrosis, culminating in liver cirrhosis and end-stage liver disease in its most severe form. The risk factors for T2DM and NAFLD have a lot of overlap, most prominent being generalised obesity along with insulin resistance & hence patients with T2DM are recognized to be at the highest risk for developing NASH and advanced fibrosis. Dr. Bharat Saboo joins us LIVE on Medflix to educate us on the recommended approach to screening, the latest guidelines for treatment , and how we can adopt these guidelines in our routine clinical practice!

NAFLD & NASH : Current Guidelines and Adoption in Clinical Practice

Director and Chief Consultant Diabetologist | PRAYAS Diabetes Centre, Indore

Dr. Bharat Saboo

4

1.5k

31.7k

4.6

Sessions Taken

301

4.7

286

4.6

304

4.7

1.3k

4.4